Top Markets
Coin of the day
Neuphoria Therapeutics Inc. Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP
Rank in Stocks #29434
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Share Price
$3.92
Last synced: 2026-07-31
Market Cap
$21.16M
Change (1 day)
-0.13%
Change (1 year)
-48.76%
Country
US
Trade Neuphoria Therapeutics Inc. (NEUP)

Category

Number of shares outstanding for Neuphoria Therapeutics Inc. (NEUP)
Number of shares outstanding as of August 2026: 0
According to Neuphoria Therapeutics Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Neuphoria Therapeutics Inc. (NEUP) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
396.00M -
US
483.58M -
AU
- -
CH